NPCE
Neuropace Inc
14.70$
+1.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.63 | 0.69 | 0.64 | 0.67 | 0.72 | 0.72 | 0.72 | 0.72 | 0.83 | 0.81 | 0.65 | 0.67 | 2.90 | |
| 0.16 | 0.17 | 0.17 | 0.18 | 0.19 | 0.18 | 0.16 | 0.16 | 0.19 | 0.18 | 0.12 | 0.11 | 0.59 | |
| 0.47 | 0.52 | 0.47 | 0.49 | 0.52 | 0.54 | 0.55 | 0.55 | 0.64 | 0.63 | 0.54 | 0.55 | 2.31 | |
| 0.18 | 0.21 | 0.20 | 0.21 | 0.20 | 0.20 | 0.24 | 0.21 | 0.20 | 0.21 | 0.21 | 0.20 | 0.81 | |
| 0.51 | 0.51 | 0.53 | 0.16 | 0.47 | 0.46 | 0.13 | 0.18 | 0.14 | 0.13 | 0.14 | 0.15 | 0.55 | |
| 0.70 | 0.72 | 0.74 | 0.71 | 0.67 | 0.66 | 0.71 | 0.76 | 0.72 | 0.68 | 0.70 | 0.71 | 2.75 | |
| -0.23 | -0.19 | -0.27 | -0.22 | -0.14 | -0.12 | -0.16 | -0.21 | -0.08 | -0.05 | -0.17 | -0.15 | -0.44 | |
| 0.08 | 0.09 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.18 | |
| -0.28 | -0.24 | -0.32 | -0.26 | -0.19 | -0.18 | -0.21 | -0.26 | -0.11 | -0.08 | -0.20 | -0.18 | -0.56 | |
| 0.09 | -0.33 | 0.01 | – | – | -0.01 | – | – | – | -0.26 | – | – | – | |
| -0.28 | -0.24 | -0.32 | -0.26 | -0.19 | -0.18 | -0.21 | -0.26 | -0.11 | -0.08 | -0.20 | -0.18 | -0.56 | |
| -0.18 | -0.14 | -0.22 | -0.17 | -0.10 | -0.09 | -0.13 | -0.19 | -0.07 | -0.02 | -0.14 | -0.13 | -0.36 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.